Riccardo Dalla-Favera was born in Legnano, Italy, in 1951 and grew up in Milan. He obtained his Medical Doctor degree from University of Milan. He moved to the U.S. in 1978 to join as a Fogarty Fellow the Laboratory of Tumor Cell Biology, National Cancer Institute, National Institutes of Health. In 1983 he joined the faculty of New York University, and in 1989 moved to Columbia University, where he is a Professor of Pathology & Cell Biology. In 1999 Dr. Dalla-Favera founded The Institute for Cancer Genetics at Columbia University, and to this day remains the Director. From 2005-2011, he also served as Director of the Herbert Irving Comprehensive Cancer Center at Columbia University

Dr. Dalla-Favera’s area of research is cancer genetics. His research team has contributed significantly to the understanding of the pathogenesis of cell malignancies, including B Cell Lymphoma, and Chronic Lymphocytic Leukemia. His work is quoted in major textbooks of medicine and oncology as it directly impacts the diagnostics and therapeutic targeting of these diseases.

Dr. Dalla-Favera’s work is widely recognized by numerous National and International prizes and awards, including the 2006 William Dameshek Prize from the American Society of Hematology (ASH), the 2017 American Association for Cancer Research GHA Clowes Memorial Award, and the 2017 Léopold Griffuel Award in Basic Research from the Association pur la Reserche sur le Cancer (ARC), France. He is an elected member of the U.S. National Academy of Medicine and the U.S. National Academy of Sciences. https://www.genetics.cumc.columbia.edu/profile/riccardo-dalla-favera-md